Duff & Phelps Investment Management Co. increased its stake in Xylem Inc. (NYSE:XYL – Free Report) by 1.5% in the second quarter, Holdings Channel reports. The firm owned 392,284 shares of the industrial products company’s stock after purchasing an additional 5,694 shares during the period. Duff & Phelps Investment Management Co.’s holdings in Xylem were worth $50,746,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds have also bought and sold shares of the stock. Price T Rowe Associates Inc. MD lifted its stake in shares of Xylem by 689.5% during the first quarter. Price T Rowe Associates Inc. MD now owns 3,708,963 shares of the industrial products company’s stock worth $443,074,000 after buying an additional 3,239,203 shares during the period. Nuveen LLC purchased a new position in Xylem in the 1st quarter worth $99,726,000. Impax Asset Management Group plc raised its stake in Xylem by 13.7% in the 2nd quarter. Impax Asset Management Group plc now owns 5,499,688 shares of the industrial products company’s stock worth $709,183,000 after acquiring an additional 663,191 shares during the last quarter. Tredje AP fonden lifted its position in Xylem by 2,441.5% during the 2nd quarter. Tredje AP fonden now owns 622,165 shares of the industrial products company’s stock worth $80,483,000 after acquiring an additional 597,685 shares during the period. Finally, Swedbank AB grew its stake in Xylem by 13.9% during the 2nd quarter. Swedbank AB now owns 4,366,932 shares of the industrial products company’s stock valued at $564,906,000 after purchasing an additional 531,890 shares during the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.
Insiders Place Their Bets
In related news, EVP Claudia S. Toussaint sold 10,421 shares of the business’s stock in a transaction dated Thursday, October 30th. The shares were sold at an average price of $152.64, for a total transaction of $1,590,661.44. Following the transaction, the executive vice president directly owned 31,250 shares in the company, valued at approximately $4,770,000. The trade was a 25.01% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Victoria D. Harker sold 1,700 shares of the company’s stock in a transaction dated Tuesday, November 4th. The shares were sold at an average price of $148.14, for a total transaction of $251,838.00. Following the sale, the director directly owned 16,875 shares of the company’s stock, valued at approximately $2,499,862.50. This represents a 9.15% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 13,121 shares of company stock valued at $1,982,459 in the last 90 days. 0.27% of the stock is owned by insiders.
Xylem Price Performance
Xylem (NYSE:XYL – Get Free Report) last announced its earnings results on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.23 by $0.14. The business had revenue of $2.27 billion for the quarter, compared to analyst estimates of $2.22 billion. Xylem had a net margin of 10.66% and a return on equity of 10.77%. The company’s revenue for the quarter was up 7.8% compared to the same quarter last year. During the same quarter last year, the business earned $1.11 earnings per share. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. As a group, research analysts predict that Xylem Inc. will post 4.65 EPS for the current fiscal year.
Xylem Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 23rd. Shareholders of record on Tuesday, November 25th will be issued a $0.40 dividend. The ex-dividend date is Tuesday, November 25th. This represents a $1.60 dividend on an annualized basis and a yield of 1.1%. Xylem’s dividend payout ratio (DPR) is presently 41.13%.
Analyst Upgrades and Downgrades
Several brokerages have recently issued reports on XYL. Cowen restated a “hold” rating on shares of Xylem in a research note on Tuesday, August 26th. Citigroup raised their price target on shares of Xylem from $173.00 to $182.00 and gave the stock a “buy” rating in a research report on Wednesday, October 29th. Mizuho set a $160.00 price objective on shares of Xylem in a report on Wednesday, October 29th. TD Cowen increased their price objective on shares of Xylem from $125.00 to $130.00 and gave the stock a “hold” rating in a research note on Tuesday, August 26th. Finally, Zacks Research upgraded shares of Xylem from a “hold” rating to a “strong-buy” rating in a research report on Monday, September 22nd. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat, Xylem presently has an average rating of “Moderate Buy” and a consensus price target of $166.90.
View Our Latest Report on Xylem
Xylem Profile
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Further Reading
- Five stocks we like better than Xylem
- What Are the U.K. Market Holidays? How to Invest and Trade
- 4 Cold-Weather Stocks to Buy as Winter Spending Heats Up
- Want to Profit on the Downtrend? Downtrends, Explained.
- Disney Stock Drops—Will Earnings Pave Way for a YouTube TV Truce?
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Meta’s Pain May Be Your Gain: Is This a Rare Buying Window?
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
